Background
Atrial fibrillation (AF) occurs frequently following cardiothoracic surgery and treatment decisions are informed by evidence‐based clinical guidelines. Outside this setting there are few data to guide clinical management.
Aim
To describe the characteristics, management and outcomes of hospitalised adult patients with new‐onset AF.
Methods
The medical emergency team (MET) database was utilised to identify patients who had a ‘MET call’ activated for tachycardia between 2015 and 2016. Patients with sinus tachycardia, pre‐existing AF/atrial flutter or other known tachyarrhythmia were excluded. Primary outcomes were length of hospital stay and in‐hospital mortality.
Results
New‐onset AF was identified in 137 patients: 68 medically managed; 38 non‐cardiothoracic post‐operative; and 31 cardiothoracic post‐operative. Mean age was 74 ± 11.6 years and 72 (53%) were male. Of 79 patients who underwent echocardiography, 80% had left atrial dilatation and 14% had reduced left ventricular ejection fraction (LVEF). Mean length of stay (LOS) was 12 days and in‐hospital mortality rate was 11%. On multivariable analysis, the odds of death during acute hospitalisation was 7.4 times higher in patients with heart failure with reduced LVEF (odds ratio 7.4, 95% confidence interval (CI) 1.23–44.8, P = 0.028). Length of acute hospital stay increased by 36% if the duration of AF was longer than 48 h (beta coefficient 0.36, 95% CI −0.015 to 0.74, P = 0.059).
Conclusion
Left ventricular systolic dysfunction in hospitalised patients with new‐onset AF is associated with increased all‐cause mortality whereas lower serum potassium levels are associated with an increased LOS. A prospective study is planned to compare outcomes based on in‐hospital treatment strategies.